Thailand mengatakan syarikat swasta boleh menyertai pelaksaan vaksin: Apa yang menjadi kebimbangan?

Foto: gencat cat, CC0, melalui Wikimedia Commons

Thailand is involving private health care companies in its COVID-19 vaccination drive after facing criticism for delays. But the decision risks creating major inequalities in vaccine pricing and accessibility.

oleh Umair Jamal

Thailand’s government has decided to allow private companies to import and sell COVID-19 vaccines, reversing a previous keputusan to restrict distribution to public hospitals.

The country has ordered 63 million COVID-19 shots, termasuk 26 million doses of the AstraZeneca vaccine which will be produced by a local company, Siam Biosains. This also includes another 2 million doses from China’s Sinovac and 35 million imported shots from AstraZeneca.

In March, health experts in Thailand said that private companies should be allowed to import 15-20 juta dos in addition to those ordered by the government in order to meet the country’s needs.

The move could accelerate vaccinations but unregulated private sector competition is likely to drive up prices and could make the vaccine inaccessible for millions across the country.

Government remains indecisive about private sector vaccination

Prime Minister Prayut Chan-ocha and his government have created confusion as to the role of private firms in the vaccine rollout. Pada bulan Januari, Prayut said that his government would permit only public hospitals to distribute imported COVID-19 vaccines. He said that private hospitals can import the drugs but wouldn’t be allowed to use them in the first phase of the inoculation drive.

The government plans to vaccinate lebih kurang 19 juta orang in the “first phase”, though it hasn’t given a timeline for this, and says half of its adult population will be vaccinated by the end of the year.

pada Februari 8, the government then seemed to walk back its decision and said that only the government can import vaccines in the initial phase. The decision left many companies disappointed as they planned to immediately begin importing vaccines from China, Russia and elsewhere in preparation for later distribution. Boon Vanasin, chairman of Thonburi Healthcare Group, kepada Reuters that the decision represented a move to monopolize vaccines.

In a separate statement, Dr. Paisarn Dunkum, secretary-general of the Thai Food and Drug Administration (FDA) said that private companies are welcome to import vaccines but they need to register beforehand.

The lack of clarity on the issue has left many wondering if the government realizes the urgency of the situation.

Foto: Kerajaan Negeri Sao Paulo, CC BY 2.0, melalui Wikimedia Commons

Government faces criticism on private sector vaccinations

Some observers worry that commercial interests may create vaccine inequality between the rich and poor and leave millions without access to the vaccine. Sudah, Thailand’s major private chain hospitals such as the Bangkok Dusit Medical Services, Bangkok Chain Hospital and Chularat Hospital are eying vaccine profits. Thonburi Healthcare Group has already received orders for vaccines from the tourism and manufacturing sectors and plans to charge around US$65 per jab (2,000 THB).

Aat Pisanwanich, an academic based at the Thai Chamber of Commerce University, believes that private companies are likely to worsen vaccine accessibility due to “the economic hardship Thais are experiencing.”

“The government itself cannot create accessibility to vaccines either, because the vaccination does not cover enough people soon enough,"Katanya.

Echoing Aat’s view, Kiat Ruxrungtham, director of the Centre of Excellence in Vaccine Research and Development at Chulalongkorn University, said that once private entities become part of Thailand’s vaccine distribution, pricing differences will create massive inequality.

“If the private hospitals set a high price for a particular vaccine, it might create an impression that what they sell is superior to what the government provides for free,"Katanya.

Besides the issue of pricing, there are fears that marginalized ethnic minorities in Thailand, which have received little government aid throughout the pandemic, may be left further behind.

“Instead of prioritizing the most vulnerable populations first, the rollout is leaving behind marginalized communities like migrant workers and stateless people," berkata Matcha Phorn-in, a human-rights activist in Chiang Mai.

In another controversial move, the government has decided to allow municipalities to import vaccine for their residents. This could leave poorer regions behind and political leaders may exploit the situation for electoral gains, undermining transparency. Elections for mayoral positions and other local posts are scheduled for later this year.

“It’s clear that local administrators are using this opportunity to boost their popularity ahead of the next elections,"kata Pita Limcharoenrut, leader of the opposition Move Forward Party.

The dynamic could create kontroversi between richer and poorer municipalities, as areas with fewer resources may be unable to procure enough doses or lack the public health systems needed to manage a vaccination campaign.

Private support for vaccine rollout can be effective if initiated properly

To address public concern, the government will have to issue clear regulations for private sector vaccine distribution. The government needs to determine many of the details for private vaccine programs, including pricing, distribution plans, accessibility and other technical issues.

Pemerintah Thailand telah dikritik kerana pelanggaran vaksinnya yang perlahan dan tekanan ini cenderung meningkat. Tetapi itu tidak bermaksud bahawa pemerintah harus meminta bantuan syarikat swasta tanpa mengadakan mekanisme pemantauan dan kebertanggungjawaban yang tepat.

Mengenai Pengarang

Umair Jamal
Umair Jamal adalah wartawan bebas dan Ph.D. calon di Universiti Otago, New Zealand. Dia boleh dihubungi di dan di Twitter @ UmairJamal15